Top Markets
#1 ADO Protocol ADO Protocol +335.27%
#2 Islamic Coin Islamic Coin +155.40%
#3 GoPlus Security GoPlus Security +45.02%
#4 Starpower Starpower +35.19%
#5 GAIB AID GAIB AID +24.67%
#6 Casper Network Casper Network +14.74%
#7 Nockchain Nockchain +12.81%
#8 Power Protocol Power Protocol +11.88%
#9 o1.exchange o1.exchange +11.28%
#10 Status Status +10.86%
Coin of the day
ADO Protocol ADO Protocol
設定
言語
日本
通貨
USD
テーマ
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

CUPR
株式のランク #33380
Cuprina Holdings (Cayman) Limited is a Singaporean biotechnology and biomedical... Cuprina Holdings (Cayman) Limited is a Singaporean biotechnology and biomedical enterprise, primarily dedicated to pioneering and bringing to market advanced solutions for the management of persistent wounds. The company produces and supplies its flagship MEDIFLY brand, which features medical-grade sterile blowfly larvae bio-dressing products designed to function as an effective biological debridement tool for chronic wounds. Beyond its core wound care business, Cuprina also extends its operations into the broader health and beauty market, where it provides a range of cosmeceutical items.
株価
$2.90
最終同期: 2026-08-14
時価総額
$7.78M
変化（1日）
-6.45%
変化（1年）
-69.54%
国
SG
取引 Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)

カテゴリー

Healthcare
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares（CUPR）の利益
2026 時点の利益 TTM: 0
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares の利益の推移（2026 〜 2026）
各年末の利益
年 利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE